What Verdica's 799 score means for AMTA
AMTA's composite score of 799 out of 850 places it in the "strong" performance band (740–799), indicating consistent compliance across the regulatory dimensions Verdica tracks. This score reflects data aggregated from state board of pharmacy records, FDA oversight, and DEA compliance monitoring—three pillars of pharmacy regulation in the United States.
A score in this range suggests that AMTA meets core regulatory expectations and maintains acceptable operational standards. However, it stops short of the "excellent" threshold (800–850), meaning there are measurable compliance gaps or areas where performance lags behind top-tier providers. For a business owner or consumer evaluating AMTA, this score signals a provider with a solid track record but room for improvement in one or more compliance areas.
The takeaway: AMTA is not a high-risk operator, but it is not flawless either. The score warrants a closer look at where performance trails, especially given that no independent customer reviews are indexed yet to offer real-world context.
How the sub-scores break down
Product Approval (850/850): AMTA received a perfect score in this dimension, indicating that its products meet FDA approval standards and pass Verdica's validation against approved pharmaceutical databases. In pharmacy compliance, this is a foundational requirement—products must be approved for their stated indications and properly labeled. A perfect score here means no indexed red flags around unapproved or misrepresented products.
Manufacturer Profile (720/850): This sub-score is the lowest of the three and represents a meaningful gap. Manufacturer profile data typically includes verification of legitimate pharmaceutical sourcing, facility certifications (such as FDA cGMP compliance for manufacturing sites), and supply chain transparency. A score of 720 suggests AMTA either has incomplete documentation in state records, minor licensing gaps, or upstream supplier issues that haven't been resolved. This is the primary driver pulling the composite score out of the "excellent" band.
FDA Compliance (830/850): AMTA scored 830 in FDA compliance, indicating strong alignment with federal pharmaceutical regulations but not perfect adherence. This dimension tracks items such as adverse event reporting (MedWatch), product recalls, warning letters, import/export compliance, and facility inspections. A score of 830 suggests AMTA has a limited compliance history—perhaps a minor citation or a resolved discrepancy—but no serious enforcement action on file.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensing records, disciplinary actions, and operational compliance data for all pharmacy entities. Regulators monitor license status, pharmacy practice violations, record-keeping failures, and compounding deviations. A provider with clean state records earns higher scores; those with warnings, probation, or license suspension see lower ratings.
The FDA oversees product approval, labeling accuracy, manufacturing standards, and facility compliance. Pharmacies and manufacturers are subject to inspections, and violations may trigger warning letters or recalls. The DEA regulates controlled substance handling, including prescription tracking via CSOS (Controlled Substance Ordering System), record retention, and physical security. Diversion—the illegal redistribution of controlled drugs—is a critical enforcement focus.
Verdica's composite methodology weighs these three regulatory streams to produce a single score. High scores reflect a clean licensing record, FDA approval for marketed products, no major recalls or warning letters, and DEA compliance with controlled substance protocols. Drops in these scores typically signal unresolved licensing issues, supply chain problems, or enforcement actions.
Bottom line
AMTA is a strong provider by compliance standards, with a score that places it well above the minimum threshold for safe operations. However, the manufacturer profile sub-score warrants scrutiny—any entity considering a business relationship should verify AMTA's sourcing documentation, facility certifications, and supplier credentials directly. Request current state pharmacy licensing confirmation and review any available FDA inspection reports before proceeding.